Inhaled corticosteroids in ventilated preterm neonates: a non-randomized dose-ranging study
Abstract Background Inhaled corticosteroids (ICS) offer targeted treatment for bronchopulmonary dysplasia (BPD) with minimal systemic effects compared to systemic steroids. However, dosing of ICS in the management of infants at high-risk of developing BPD is not well established. The objective of th...
Main Authors: | Kamini Raghuram, Michael Dunn, Krista Jangaard, Maureen Reilly, Elizabeth Asztalos, Edmond Kelly, Michael Vincer, Vibhuti Shah |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-05-01
|
Series: | BMC Pediatrics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12887-018-1134-7 |
Similar Items
-
Pharmacoepidemiology of Drug Exposure in Intubated and Non-Intubated Preterm Infants With Severe Bronchopulmonary Dysplasia
by: T. Lewis, et al.
Published: (2021-07-01) -
Airway administration of corticosteroids for prevention of bronchopulmonary dysplasia in premature infants: a meta-analysis with trial sequential analysis
by: Zhi-Qun Zhang, et al.
Published: (2017-12-01) -
Use of Inhaled Corticosteroids and Risk of Cataracts: a Case-Control Study
by: A Miratashi, et al.
Published: (2005-07-01) -
The Impact of Postnatal Systemic Steroids on the Growth of Preterm Infants: A Multicenter Cohort Study
by: Carlos Zozaya, et al.
Published: (2019-11-01) -
Which inhaled corticosteroid and long-acting β-agonist combination is better in patients with moderate-to-severe asthma, a dry powder inhaler or a pressurized metered-dose inhaler?
by: Masato Muraki, et al.
Published: (2017-01-01)